decentralized-trials
(4)
Scott Weidley
Scott Weidley is President, CEO and Chief Engineer of ClinCapture, the Las Vegas eClinical company that built its reputation on giving away validated electronic data capture software for free. With two decades in cloud and clinical software, Weidley has steered ClinCapture's Captivate platform toward AI baked into the structural layer of trial design, championed a low-and-no-cost access program called Weidley's Wish, and reinvented himself as a podcaster whose show 'Vibe with Scott Weidley' broadcasts from Vegas and has crossed three million YouTube views.
Anthony Costello
Anthony Costello is the CEO of Medidata Solutions, a Dassault Systèmes company, and one of clinical research technology's most seasoned architects. With nearly 30 years in the field, he started as a data manager at Genentech, co-founded two companies (Nextrials and Mytrus), and was acquired by Medidata before rising to lead it. Today he oversees over 8,000 active clinical studies globally each year, championing AI-driven trial innovation, decentralized models, and patient-centric design at the White House Clinical Trials Forum and beyond.
Mika Newton
Mika Newton is the CEO of xCures Inc., an Oakland-based AI company transforming how cancer patients and oncologists navigate clinical data. With over two decades in life sciences and health technology, she leads a platform that automatically retrieves, structures, and surfaces medical records to support real-world evidence generation and precision oncology - helping patients find clinical trials and helping researchers capture regulatory-grade data at scale.
Mike Novotny
Mike Novotny is the founder and CEO of Medrio, a San Francisco-based eClinical SaaS company he started in his apartment in 2005. Over 15 years he bootstrapped Medrio into a nine-figure company that has helped customers win regulatory approvals for more than 100 treatments. After a sabbatical researching organizational development, he returned as CEO in 2025, betting that AI will reshape clinical trial data management. Before Medrio, he was CEO of Telosa, President of Ninaza, a UN research associate, and managed the fraud database at Visa. He holds degrees from Stanford, PUC Chile, and Columbia.